May 1, 2009
GLOSTRUP, DENMARK--(May 1, 2009) - Dako, Reagent Partnership Division, has entered into a five-year agreement with Fisher HealthCare, a division of Thermo Fisher Scientific. Under this agreement, Fisher Healthcare has been granted the exclusive right to distribute Flow Cytometry reagents in the US acute care market, including hospitals and reference labs. Dako, Reagent Partnership Division, [...]
Jerini AG Reaches Agreement to Sell JPT Peptide Technologies GmbH to TheraCode GmbH
May 1, 2009
Berlin, May 1, 2009 - Jerini AG has reached an agreement to sell its wholly-owned subsidiary, JPT Peptide Technologies GmbH to TheraCode GmbH, Mainz, a wholly-owned subsidiary of BioNTech AG, Mainz. Under the terms of the agreement, TheraCode GmbH will pay Jerini AG a purchase price of approximately € 5 million in cash. The sale [...]
AnaSpec Introduces New SensoLyte Anti-Human MOG 1-125 IgG ELISA Kit
May 1, 2009
NewswireToday - /newswire/ - San Jose, CA, United States, 05/01/2009 - AnaSpec has announced the release of the newest addition to its Anti-MOG ELISA assay kit series – the SensoLyte Anti-Human MOG (1-125) IgG Quantitation ELISA Kit. This kit, along with previously featured SensoLyte Anti-Mouse MOG (1-125) and SensoLyte Anti-Rat MOG (1-125) IgG ELISA assay [...]
Johnson Bottini, LLP Files Class Action on Behalf of Purchasers of Sequenom, Inc.
May 1, 2009
SAN DIEGO--Johnson Bottini, LLP today announced that it has filed a class action lawsuit in United States District Court for the Southern District of California on behalf of all persons who purchased or otherwise acquired securities of Sequenom, Inc. (NASDAQ:SQNM - News) between June 4, 2008 and April 29, 2009. If you are a member [...]
May 1, 2009
Guildford, UK, May 1, 2009 – IDBS, the global provider of data management solutions for research and development companies, announces that CSIRO Molecular and Health Technology is increasing its use of IDBS' E-WorkBook for chemistry (ChemBook) in support of its internationally acclaimed polymer research. CSIRO are the developers of the groundbreaking RAFT technology in polymer [...]
May 1, 2009
BOTHELL, Wash.--BLUE HERON BIOTECHNOLOGY announced today that it delivered a critical synthetic DNA gene sequence in just three days in response to the National Institutes of Health request for assistance in combating the outbreak of Swine Flu. “We are gratified that the NIH has placed their confidence and trust in Blue Heron in this time [...]
New Workspace Protects Microarrays from Harmful Ozone
May 1, 2009
Creates an Ozone-Safe Environment for Automated or Manual Microarray Processing May 01, 2009, SciGene (Sunnyvale, CA) today announced the introduction of the NoZone® WS Workspace, a new benchtop system for maintaining an ozone-safe environment when operating microarray scanning and processing equipment. The workspace consists of a benchtop polycarbonate enclosure with an external high efficiency ozone [...]
Law Offices of Howard G. Smith Announces Investigation On Behalf of Investors of Sequenom, Inc.
May 1, 2009
BENSALEM, Pa.--Law Offices of Howard G. Smith announces that it is investigating potential claims against Sequenom, Inc. (“Sequenom” or the “Company”) (Nasdaq:SQNM - News), concerning possible securities violations related to public statements made by the Company between June 4, 2008 and April 29, 2009. The investigation focuses on allegations that certain statements made by the [...]
Law Office of Brodsky & Smith, LLC Announces Class Action Lawsuit Against Sequenom, Inc.
May 1, 2009
BALA CYNWYD, PA--May 1, 2009 -- Law office of Brodsky & Smith, LLC announces that a class action lawsuit has been filed on behalf of all persons who purchased common stock of Sequenom, Inc. ("Sequenom" or the "Company") (NasdaqGM:SQNM - News) between June 4, 2008 and April 29, 2009 (the "Class Period"). The class action [...]
MaxCyte GT Flow Transfection System Now Available to Academic and Clinical Investigators
April 30, 2009
cGMP-Compliant, Validated Technology Enhances Biological Activity Enabling Clinical Delivery of Safe and Effective Cellular Therapeutics GAITHERSBURG, Md.--MaxCyte today announces the launch of the MaxCyte® GT™ Flow Transfection System to academic and clinical investigators. The MaxCyte® GT™ Flow Transfection System is a validated platform for optimizing the biological activity of cellular therapeutic products. The system, which [...]

